Effects of Na/K-ATPase and its ligands on bone marrow stromal cell differentiation

Stem Cell Research

Volumn 13, Issue 1, 2014, Pages 12-23

  Sayed, Moustafa ^a   Drummond, Christopher A ^a   Evans, Kaleigh L ^a   Haller, Steven T ^a   Liu, Jiang ^b   Xie, Zijian ^a   Tian, Jiang ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ASCORBIC ACID; CCAAT ENHANCER BINDING PROTEIN ALPHA; GLYCEROL 2 PHOSPHATE; MARINOBUFAGENIN; MITOGEN ACTIVATED PROTEIN KINASE; ROSIGLITAZONE; TRANSCRIPTION FACTOR RUNX2; 2,4 THIAZOLIDINEDIONE DERIVATIVE; BUFADIENOLIDE DERIVATIVE; CCAAT ENHANCER BINDING PROTEIN;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE MARROW STROMAL CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STROMA CELL; 3T3 CELL LINE; ANIMAL; BOVINAE; CYTOLOGY; DRUG EFFECTS; DRUG POTENTIATION; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

3T3-L1 CELLS; ADIPOGENESIS; ANIMALS; BONE MARROW CELLS; BUFANOLIDES; CATTLE; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; DRUG SYNERGISM; ENZYME ACTIVATION; MALE; MESENCHYMAL STROMAL CELLS; MICE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM-POTASSIUM-EXCHANGING ATPASE; THIAZOLIDINEDIONES;

EID: 84899764360     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.04.002     Document Type: Article

References (78)

1. Adams D.S., Masi A., Levin M. H+pump-dependent changes in membrane voltage are an early mechanism necessary and sufficient to induce Xenopus tail regeneration. Development 2007, 134:1323-1335.
2. Aizman O., Aperia A. Na, K-ATPase as a signal transducer. Ann. N. Y. Acad. Sci. 2003, 986:489-496.
3. Akera T., Brody T.M. Inotropic action of digitalis and ion transport. Life Sci. 1976, 18:135-144.
4. Aubert J., Dessolin S., Belmonte N., Li M., McKenzie F.R., Staccini L., Villageois P., Barhanin B., Vernallis A., Smith A.G., et al. Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade. J. Biol. Chem. 1999, 274:24965-24972.
5. Bagrov A.Y., Shapiro J.I., Fedorova O.V. Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol. Rev. 2009, 61:9-38.
6. Baldwin D., Duffin K.E. Rosiglitazone treatment of diabetes mellitus after solid organ transplantation. Transplantation 2004, 77:1009-1014.
7. Balzan S., Neglia D., Ghione S., D'Urso G., Baldacchino M.C., Montali U., L'Abbate A. Increased circulating levels of ouabain-like factor in patients with asymptomatic left ventricular dysfunction. Eur. J. Heart Fail. 2001, 3:165-171.
8. Banfi A., Muraglia A., Dozin B., Mastrogiacomo M., Cancedda R., Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp. Hematol. 2000, 28:707-715.
9. Barry W.H., Hasin Y., Smith T.W. Sodium pump inhibition, enhanced calcium influx via sodium-calcium exchange, and positive inotropic response in cultured heart cells. Circ. Res. 1985, 56:231-241.
10. Belmonte N., Phillips B.W., Massiera F., Villageois P., Wdziekonski B., Saint-Marc P., Nichols J., Aubert J., Saeki K., Yuo A., et al. Activation of extracellular signal-regulated kinases and CREB/ATF-1 mediate the expression of CCAAT/enhancer binding proteins beta and -delta in preadipocytes. Mol. Endocrinol. 2001, 15:2037-2049.
11. Beresford J.N., Bennett J.H., Devlin C., Leboy P.S., Owen M.E. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J. Cell Sci. 1992, 102(Pt 2):341-351.
12. Bianco P., Robey P.G., Simmons P.J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008, 2:313-319.
13. Bianco P., Cao X., Frenette P.S., Mao J.J., Robey P.G., Simmons P.J., Wang C.Y. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 2013, 19:35-42.
14. Bost F., Caron L., Marchetti I., Dani C., Le Marchand-Brustel Y., Binetruy B. Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem. J. 2002, 361:621-627.
15. Bost F., Aouadi M., Caron L., Binetruy B. The role of MAPKs in adipocyte differentiation and obesity. Biochimie 2005, 87:51-56.
16. Boxall S.A., Jones E. Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int. 2012, 2012:975871.
17. Chen S.L., Fang W.W., Ye F., Liu Y.H., Qian J., Shan S.J., Zhang J.J., Chunhua R.Z., Liao L.M., Lin S., et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 2004, 94:92-95.
18. Christy R.J., Yang V.W., Ntambi J.M., Geiman D.E., Landschulz W.H., Friedman A.D., Nakabeppu Y., Kelly T.J., Lane M.D. Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev. 1989, 3:1323-1335.
19. Cignarelli M., Lamacchia O. Obesity and kidney disease. Nutr. Metab. Cardiovasc. Dis. 2007, 17:757-762.
20. Couttenye M.M., D'Haese P.C., Verschoren W.J., Behets G.J., Schrooten I., De Broe M.E. Low bone turnover in patients with renal failure. Kidney Int. Suppl. 1999, 73:S70-S76.
21. Elkareh J., Kennedy D.J., Yashaswi B., Vetteth S., Shidyak A., Kim E.G., Smaili S., Periyasamy S.M., Hariri I.M., Fedorova L., et al. Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension 2007, 49:215-224.
22. Fedorova O.V., Doris P.A., Bagrov A.Y. Endogenous marinobufagenin-like factor in acute plasma volume expansion. Clin. Exp. Hypertens. 1998, 20:581-591.
23. Fidan E., Onder Ersoz H., Yilmaz M., Yilmaz H., Kocak M., Karahan C., Erem C. The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol. 2011, 48:297-302.
24. Franceschi R.T., Xiao G. Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J. Cell. Biochem. 2003, 88:446-454.
25. Fridman A.I., Matveev S.A., Agalakova N.I., Fedorova O.V., Lakatta E.G., Bagrov A.Y. Marinobufagenin, an endogenous ligand of alpha-1 sodium pump, is a marker of congestive heart failure severity. J. Hypertens. 2002, 20:1189-1194.
26. Friedenstein A.J., Chailakhjan R.K., Lalykina K.S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970, 3:393-403.
27. Gottlieb S.S., Rogowski A.C., Weinberg M., Krichten C.M., Hamilton B.P., Hamlyn J.M. Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 1992, 86:420-425.
28. Haas M., Wang H., Tian J., Xie Z. Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J. Biol. Chem. 2002, 277:18694-18702.
29. Hall J.E., Kuo J.J., da Silva A.A., de Paula R.B., Liu J., Tallam L. Obesity-associated hypertension and kidney disease. Curr. Opin. Nephrol. Hypertens. 2003, 12:195-200.
30. Hamlyn J.M., Blaustein M.P., Bova S., DuCharme D.W., Harris D.W., Mandel F., Mathews W.R., Ludens J.H. Identification and characterization of a ouabain-like compound from human plasma. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:6259-6263.
31. Hamm J.K., el Jack A.K., Pilch P.F., Farmer S.R. Role of PPAR gamma in regulating adipocyte differentiation and insulin-responsive glucose uptake. Ann. N. Y. Acad. Sci. 1999, 892:134-145.
32. Harting M., Jimenez F., Pati S., Baumgartner J., Cox C. Immunophenotype characterization of rat mesenchymal stromal cells. Cytotherapy 2008, 10:243-253.
33. He S., Nakada D., Morrison S.J. Mechanisms of stem cell self-renewal. Annu. Rev. Cell Dev. Biol. 2009, 25:377-406.
34. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., Koo W.W., Gordon P.L., Neel M., Sussman M., Orchard P., Marx J.C., Pyeritz R.E., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 1999, 5:309-313.
35. Horwitz E.M., Gordon P.L., Koo W.K., Marx J.C., Neel M.D., McNall R.Y., Muul L., Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:8932-8937.
36. Hosoda T. C-kit-positive cardiac stem cells and myocardial regeneration. Am. J. Cardiovasc. Dis. 2012, 2:58-67.
37. Karaoz E., Aksoy A., Ayhan S., Sariboyaci A.E., Kaymaz F., Kasap M. Characterization of mesenchymal stem cells from rat bone marrow: ultrastructural properties, differentiation potential and immunophenotypic markers. Histochem. Cell Biol. 2009, 132:533-546.
38. Karsenty G., Ducy P., Starbuck M., Priemel M., Shen J., Geoffroy V., Amling M. Cbfa1 as a regulator of osteoblast differentiation and function. Bone 1999, 25:107-108.
39. Kennedy D.J., Vetteth S., Periyasamy S.M., Kanj M., Fedorova L., Khouri S., Kahaleh M.B., Xie Z., Malhotra D., Kolodkin N.I., et al. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 2006, 47:488-495.
40. Kennedy D.J., Elkareh J., Shidyak A., Shapiro A.P., Smaili S., Mutgi K., Gupta S., Tian J., Morgan E., Khouri S., et al. Partial nephrectomy as a model for uremic cardiomyopathy in the mouse. Am. J. Physiol. Renal Physiol. 2008, 294:F450-F454.
41. Koc O.N., Day J., Nieder M., Gerson S.L., Lazarus H.M., Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 2002, 30:215-222.
42. Kramer H. Obesity and chronic kidney disease. Contrib. Nephrol. 2006, 151:1-18.
43. Laredo J., Shah J.R., Lu Z.R., Hamilton B.P., Hamlyn J.M. Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors. Hypertension 1997, 29:401-407.
44. Lee Y.K., Ng K.M., Lai W.H., Man C., Lieu D.K., Lau C.P., Tse H.F., Siu C.W. Ouabain facilitates cardiac differentiation of mouse embryonic stem cells through ERK1/2 pathway. Acta Pharmacol. Sin. 2011, 32:52-61.
45. Li X., Cui Q., Kao C., Wang G.J., Balian G. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 2003, 33:652-659.
46. Li J., Zelenin S., Aperia A., Aizman O. Low doses of ouabain protect from serum deprivation-triggered apoptosis and stimulate kidney cell proliferation via activation of NF-kappaB. J. Am. Soc. Nephrol. 2006, 17:1848-1857.
47. Liu C., Bai Y., Chen Y., Wang Y., Sottejeau Y., Liu L., Li X., Lingrel J.B., Malhotra D., Cooper C.J., et al. Reduction of Na/K-ATPase potentiates marinobufagenin-induced cardiac dysfunction and myocyte apoptosis. J. Biol. Chem. 2012, 287:16390-16398.
48. MacDougald O.A., Cornelius P., Liu R., Lane M.D. Insulin regulates transcription of the CCAAT/enhancer binding protein (C/EBP) alpha, beta, and delta genes in fully-differentiated 3T3-L1 adipocytes. J. Biol. Chem. 1995, 270:647-654.
49. Majumdar M.K., Thiede M.A., Mosca J.D., Moorman M., Gerson S.L. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J. Cell. Physiol. 1998, 176:57-66.
50. Manunta P., Stella P., Rivera R., Ciurlino D., Cusi D., Ferrandi M., Hamlyn J.M., Bianchi G. Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension 1999, 34:450-456.
51. Maric-Bilkan C. Obesity and diabetic kidney disease. Med. Clin. N. Am. 2013, 97:59-74.
52. Martin K.J., Gonzalez E.A. Metabolic bone disease in chronic kidney disease. J. Am. Soc. Nephrol. 2007, 18:875-885.
53. Moe S., Drueke T., Cunningham J., Goodman W., Martin K., Olgaard K., Ott S., Sprague S., Lameire N., Eknoyan G., et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006, 69:1945-1953.
54. Nanbu-Wakao R., Fujitani Y., Masuho Y., Muramatu M., Wakao H. Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Mol. Endocrinol. 2000, 14:307-316.
55. Noh H., Yu M.R., Kim H.J., Jeon J.S., Kwon S.H., Jin S.Y., Lee J., Jang J., Park J.O., Ziyadeh F., et al. Uremia induces functional incompetence of bone marrow-derived stromal cells. Nephrol. Dial. Transplant. 2012, 27:218-225.
56. Otsu K., Kuruma A., Yanagida E., Shoji S., Inoue T., Hirayama Y., Uematsu H., Hara Y., Kawano S. Na+/K+ATPase and its functional coupling with Na+/Ca2+ exchanger in mouse embryonic stem cells during differentiation into cardiomyocytes. Cell Calcium 2005, 37:137-151.
57. Palazzuoli A., Ronco C. Cardio-renal syndrome: an entity cardiologists and nephrologists should be dealing with collegially. Heart Fail. Rev. 2011, 16:503-508.
58. Pantoja C., Huff J.T., Yamamoto K.R. Glucocorticoid signaling defines a novel commitment state during adipogenesis in vitro. Mol. Biol. Cell 2008, 19:4032-4041.
59. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
60. Prusty D., Park B.H., Davis K.E., Farmer S.R. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J. Biol. Chem. 2002, 277:46226-46232.
61. Sacchetti B., Funari A., Michienzi S., Di Cesare S., Piersanti S., Saggio I., Tagliafico E., Ferrari S., Robey P.G., Riminucci M., et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
62. Satomura K., Krebsbach P., Bianco P., Gehron Robey P. Osteogenic imprinting upstream of marrow stromal cell differentiation. J. Cell. Biochem. 2000, 78:391-403.
63. Schoner W. Endogenous cardiac glycosides, a new class of steroid hormones. Eur. J. Biochem. 2002, 269:2440-2448.
64. Short B., Brouard N., Occhiodoro-Scott T., Ramakrishnan A., Simmons P.J. Mesenchymal stem cells. Arch. Med. Res. 2003, 34:565-571.
65. Simoes E.S.A.C., Flynn J.T. The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease. Pediatr. Nephrol. 2012, 10:1835-1845.
66. Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R.V., Kogler G., Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106:1913-1918.
67. Sundelacruz S., Levin M., Kaplan D.L. Membrane potential controls adipogenic and osteogenic differentiation of mesenchymal stem cells. PLoS One 2008, 3:e3737.
68. Tian J., Cai T., Yuan Z., Wang H., Liu L., Haas M., Maksimova E., Huang X.Y., Xie Z.J. Binding of Src to Na+/K+-ATPase forms a functional signaling complex. Mol. Biol. Cell 2006, 17:317-326.
69. Tian J., Li X., Liang M., Liu L., Xie J.X., Ye Q., Kometiani P., Tillekeratne M., Jin R., Xie Z. Changes in sodium pump expression dictate the effects of ouabain on cell growth. J. Biol. Chem. 2009, 284:14921-14929.
70. Tian J., Haller S., Periyasamy S., Brewster P., Zhang H., Adlakha S., Fedorova O.V., Xie Z.J., Bagrov A.Y., Shapiro J.I., et al. Renal ischemia regulates marinobufagenin release in humans. Hypertension 2010, 56:914-919.
71. Wang D., Haile A., Jones L.C. Rosiglitazone-induced adipogenesis in a bone marrow mesenchymal stem cell line - biomed 2011. Biomed. Sci. Instrum. 2011, 47:213-221.
72. Wickman C., Kramer H. Obesity and kidney disease: potential mechanisms. Semin. Nephrol. 2013, 33:14-22.
73. Wu Z., Rosen E.D., Brun R., Hauser S., Adelmant G., Troy A.E., McKeon C., Darlington G.J., Spiegelman B.M. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 1999, 3:151-158.
74. Xie Z., Cai T. Na+-K+-ATPase-mediated signal transduction: from protein interaction to cellular function. Mol. Interv. 2003, 3:157-168.
75. Yin T., Li L. The stem cell niches in bone. J. Clin. Invest. 2006, 116:1195-1201.
76. You M.H., Song M.S., Lee S.K., Ryu P.D., Lee S.Y., Kim D.Y. Voltage-gated K+channels in adipogenic differentiation of bone marrow-derived human mesenchymal stem cells. Acta Pharmacol. Sin. 2013, 34:129-136.
77. Zhang Y.Y., Yue J., Che H., Sun H.Y., Tse H.F., Li G.R. BKCa and hEag1 channels regulate cell proliferation and differentiation in human bone marrow-derived mesenchymal stem cells. J. Cell. Physiol. 2014, 229:202-212.
78. Zhao L.R., Berra H.H., Duan W.M., Singhal S., Mehta J., Apkarian A.V., Kessler J.A. Beneficial effects of hematopoietic growth factor therapy in chronic ischemic stroke in rats. Stroke 2007, 38:2804-2811.